What this instrument does
The National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment (November Update) Instrument 2026 is a minor update to the Federal rules that control how chemotherapy drugs are funded and supplied through the Pharmaceutical Benefits Scheme (PBS). It amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024.
The instrument was registered on 30 October 2026 and took immediate effect. The source text does not specify exactly what the amendments change within the chemotherapy funding arrangement, only that Schedule 1 contains amendments to the existing 2024 arrangement.
Administration
This type of change is administered by the Department of Health, Disability and Ageing.
Who this is relevant to
This update is described as most relevant to pharmacies and health providers involved in dispensing or billing chemotherapy medicines under the PBS, rather than to small businesses generally.
Key actions
- Pharmacies or health businesses involved in chemotherapy drug supply or PBS billing can view the full legislative text and explanatory statement at https://www.legislation.gov.au/F2026L01457 to check what specifically changed in Schedule 1.
- Check with software or billing providers whether any system updates are needed to reflect this amendment to the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.